Biotech startup Auristone secures US$4 million seed funding round led by Elev8.vc

Biotech startup Auristone secures US$4 million seed funding round led by Elev8.vc

Auristone, a biotech startup, has secured a US$4 million seed funding round led by venture capital firm Elev8.vc.

• Auristone's Focus on Epigenomics: Founded in 2021 by Jingming Chew, Patrick Tan Ph.D., and Teh Tean Ph.D., the startup is focused on epigenomics, the science of how genes are expressed.

• About the Product: Their flagship product, EPI-CALL, is a molecular profiling technology that helps predict an individual's likelihood of response to different treatment options for cancer.

• Utilization of Funding: The funding will be used to drive more clinical collaborations and market adoption of EPI-CALL.

Seeds Capital, the investment arm of Enterprise Singapore, along with existing investor Genedant, joined the round of funding.